Immunovia AB (publ) to Discuss COVID-19 and IMMray™ PanCan-d Launch Preparations Conference Call Transcript
Hello and welcome to the Immunovia COVID-19 Update #4 Conference Call. My name is Caris, and I will be your coordinator for today's event. (Operator Instructions)
I will now hand you over to your host, Mats Grahn, to begin today's conference. Thank you.
()-
Thank you, and good afternoon or good morning, depending from where you are. Thanks for joining in to the update #4 of the COVID impact for Immunovia.
We will today go through the agenda, as we normally do, our response to the COVID-19 pandemic in general, but the focus of today will be the very positive news that we now can open and have opened our laboratory in Massachusetts in U.S. And then we'll go through the remaining steps to launch, commercial preparations that's ongoing and touch upon the prospective studies.
Let's start with the response to the COVID-19 pandemic. As we have talked about before, we have continued with our work at -- from home policies, and we were, as a company, very used to running virtual
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
